Tech Company Financing Transactions
ImmuneWalk Therapeutics Funding Round
On 5/8/2025, ImmuneWalk Therapeutics raised $7 million in Seed funding from private investors.
Transaction Overview
Company Name
Announced On
5/8/2025
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
1 Blue Hill Plaza, Pearl River
New York, NY 10965
USA
New York, NY 10965
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
ImmuneWalk Therapeutics is a private clinical-stage company focused on development of novel therapies for chronic inflammatory diseases. Our Monocyte Targeting Technology (MTT) is designed to selectively block the migration (`walking`) of monocytes from the blood stream into inflamed tissues.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dror Harats
Browse more venture capital transactions:
Prev: 5/8/2025: Atombit venture capital transaction
Next: 5/8/2025: mPower Technology venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on all VC transactions involving tech companies. All VC database entries reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs